Our Approach

We make long-term bets on scientific & technological breakthroughs. When we have original ideas – such as being the first in this century to re-think the medical use of psychedelics - we incubate companies inspiring radical structural change.

We particularly like platform and roll-up strategies with centralized services, leadership & business development, supporting founders and scientists with our entrepreneurial vision and company-building capability.

We have raised more than US$ 1 billion outside money in recent years for our various platform companies.

A few selected portfolio companies:

We take active minority stakes in listed companies mainly through IPOs & SPACs, but sometimes also later in a company’s life cycle.

We offer our listed companies the same attention and value-add as we give our venture portfolio.

Primarily, we are initiating and sponsoring our own SPACs – often together with strategic partners – focusing on certain high growth industries and/or regions.

Additionally, we are investing into the SPACs of other sponsors, offering SPAC sponsors an entrepreneurial, long-term investor & partner who not only provides capital, but also and especially deal flow.

A few selected portfolio companies:

Our Venture Capital fund Elevat3 Capital focuses on lead or co-lead investments in European tech companies across the Apeiron sectors.

The fund is managed by Christian Angermayer, Thomas Hanke and Dr. Marlon Braumann with Peter Thiel's Founders Fund as strategic partner.

A few selected portfolio companies:

With our flagship fund Presight Capital we follow a very flexible, diversified approach, investing globally in the most ambitious founders, at any stage and any sector, always together with leading VCs.

Presight’s mission is to be a steadfast and committed partner to outlier entrepreneurs. Presight Capital is a full lifecycle investor and writes tickets in the range of $500k to $20m and from seed to growth.

Across its 2 funds and several SPVs, Presight Capital manages more than $700M in Assets under Management.

Presight currently has more than 50 portfolio companies. A few selected portfolio companies:

Presight Partners is a new fund-of-funds building a concentrated global portfolio of exceptional early-stage venture funds.

We leverage the Apeiron network and ecosystem to be a value additive investor and gain competitive access to top performing managers.

With Presight Partners, we exercise the same entrepreneurial approach to investing in funds as we do when investing directly in companies.

Our focus lies on first-time funds and emerging managers, to whom we want to be a long-term, reliable partner and investor.

re.Mind is a venture fund exclusively focused on mental and neurological health.

We invest from Seed to Pre-IPO, particularly in biotech, digital, clinics and brain-computer interfaces.

With US$ 150 million under management, re.Mind ONE is the leading global fund focusing on mental health. 

re.Mind benefits from Apeiron’s extensive network of entrepreneurs and investors in the sector, thanks to our pioneering work with psychedelics.

Alpine Space Ventures is a NewSpace-focused Venture Capital fund.

Run by a team of experienced investors, entrepreneurs, engineers and business executives with direct NewSpace experience, and combining European leadership in tech innovation and industrial leadership with US-style entrepreneurship and company-building thinking, we invest in European space start-ups from seed stage to series-A with the capacity to provide growth capital for our portfolio companies.

A few selected portfolio companies: